this is an important issue to internalize:

so much defense and resistance to COV-19 is based in t-cells, that sero-prevalence of antibodies can be a very misleading figure.

in this german study, only 52% of PCR confirmed COV cases had antibodies @ 6wks

https://www.medrxiv.org/content/10.1101/2020.07.15.20154112v1.full.pdf
and this was a thorough test

they ran 6 different IgG immunoassays. had it been just one (as is typical) this could have been considerably lower

so it's very possible that many antibody studies are under-counting prevalence by 50% or more. could easily be 75%+

no way to know
this is why IgG tests are not generally used to assess disease prevalence. they're just not that meaningful and can vary in unpredictable ways.

so "only 6% of people have antibodies" is just not that meaningful. that could be 6% disease prevalence or 24% or 40%.
but keep in mind that this also does NOT mean there is no resistance.

SARS-1 has strong, specific t-cell mediated resistance 17 years later (and this is cross resistant to covid-19) https://twitter.com/boriquagato/status/1284134457348362240?s=20
herd immunity looks to be 10-30% (depending on location) not the 60-70% those who assumed no cross resistant immunity were originally postulating (and a base assumption of the HIT= 1-(1/r0) equation. https://twitter.com/boriquagato/status/1259552285102727168?s=20
a lot of bad, messy data and assumptions are being made to drive a lot of bad, messy policy here.

so keep the limits of what you're looking at in mind.

it's keep you from being misled.
You can follow @boriquagato.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.